We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$821B
AUM Growth
+$62.3B
Cap. Flow
+$13.8B
Cap. Flow %
1.68%
Top 10 Hldgs %
16.79%
Holding
7,579
New
752
Increased
3,315
Reduced
2,057
Closed
651

Sector Composition

Rank Sector Weight
1 Technology 17.16%
2 Healthcare 10.79%
3 Financials 9.36%
4 Consumer Discretionary 8.67%
5 Industrials 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OYST
7276
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-25,532
Closed -$285K
CORZ
7277
DELISTED
Core Scientific, Inc. Common Stock
CORZ
-2,890
Closed
DS
7278
DELISTED
Drive Shack Inc.
DS
-192
Closed
PCSB
7279
DELISTED
PCSB Financial Corporation
PCSB
-8,748
Closed -$167K
CHRA
7280
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$0 ﹤0.01%
1
KAL
7281
DELISTED
Kalera Public Limited Company Ordinary Shares
KAL
$0 ﹤0.01%
106
-16,821
-99% -$91.3K
HTGM
7282
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$0 ﹤0.01%
10
+9
+900% +$34
NH
7283
DELISTED
NantHealth, Inc
NH
$0 ﹤0.01%
1
UPH
7284
DELISTED
UpHealth, Inc.
UPH
-1
Closed
ELOX
7285
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$0 ﹤0.01%
1
DBGI
7286
Digital Brands Group
DBGI
$9.08M
0
QTNT
7287
DELISTED
Quotient Limited Ordinary Shares
QTNT
-8
Closed
AMPE
7288
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$0 ﹤0.01%
1
ATHX
7289
DELISTED
Athersys, Inc. Common Stock
ATHX
$0 ﹤0.01%
25
XELA
7290
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$0 ﹤0.01%
42
+17
+68% +$206
CALA
7291
DELISTED
Calithera Biosciences, Inc
CALA
-24,345
Closed -$79K
PTE
7292
DELISTED
PolarityTE, Inc. Common Stock
PTE
$0 ﹤0.01%
8
ZOM
7293
DELISTED
Zomedica Corp.
ZOM
$0 ﹤0.01%
913
AVEO
7294
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-172,658
Closed -$2.58M
BLPH
7295
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-100
Closed
CFRX
7296
DELISTED
ContraFect Corporation
CFRX
$0 ﹤0.01%
62
-1
-2% -$5
VISL
7297
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
0
HZNP
7298
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-400
Closed -$46K
MFGP
7299
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
-4,664
Closed -$29K
NAVB
7300
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$0 ﹤0.01%
1,300

Similar funds

JP Morgan Chase's Q1 2023 Portfolio in Review

As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
  • JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
  • JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
  • JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
  • JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.